Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bio Inks $10M Loan Facility

NEW YORK (GenomeWeb) – Twist Bioscience today announced that it has secured a loan facility of up to $10 million with Silicon Valley Bank.

The San Francisco-based synthetic DNA manufacturer said that it can draw upon an unspecified portion of the loan immediately, while the remainder of the funds will be available upon the completion of certain milestones.

"This new loan facility provides flexibility within our business model to pursue strategic opportunities while maintaining our focus on product development," Twist Bio CEO Emily Leproust said in a statement.

The company has developed a semiconductor-based synthetic DNA manufacturing platform for producing tools such as oligonucleotides, genes, pathways, and genomes. Earlier this year, Twist Bio raised $26 million in a Series B financing round.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.